Home
About
Publications Trends
Recent Publications
Expert Search
Archive
systemic chemotherapy
What Types of Drugs are Used in Systemic Chemotherapy?
There are several classes of chemotherapy drugs, each working in different ways to target cancer cells. Common types include:
Alkylating agents
- damage DNA to prevent cancer cell replication.
Antimetabolites
- interfere with DNA and RNA synthesis.
Anthracyclines
- inhibit enzymes involved in DNA replication.
Topoisomerase inhibitors
- disrupt DNA unwinding necessary for replication.
Mitotic inhibitors
- prevent cell division by interfering with the mitotic spindle.
Frequently asked queries:
What is Systemic Chemotherapy?
How Does Systemic Chemotherapy Work?
When is Systemic Chemotherapy Used?
What Types of Drugs are Used in Systemic Chemotherapy?
What are the Side Effects of Systemic Chemotherapy?
How is the Effectiveness of Systemic Chemotherapy Monitored?
What are the Advances in Systemic Chemotherapy?
What Should Patients Know Before Starting Systemic Chemotherapy?
How Does SAR Work?
What are Calcineurin Inhibitors?
Who Attends Tumor Board Meetings?
What are the Challenges of Spontaneous Reporting Systems in Cancer?
How are Wearable Devices Enhancing Cancer Patient Monitoring?
What Are the Benefits of Sponsorship for Cancer Research?
What is Alveolar Rhabdomyosarcoma?
Why Inhibit Lipases in Cancer Treatment?
What is Denial in Cancer Patients?
What About Caregivers and Family Members?
What is Magnetic Resonance Spectroscopy (MRS)?
What are DNA Markers?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe